Bumper Offer - Urjas oil Just @ Rs. 1
Lamitor DT 50 Tablet is a prescription medicine that is available as a Tablet. Seizures are some of its major therapeutic uses. The alternative uses of Lamitor DT 50 Tablet have also been explained below.
The optimal dosage of Lamitor DT 50 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Lamitor DT 50 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Lamitor DT 50 Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Lamitor DT 50 Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Lamitor DT 50 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Lamitor DT 50 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Depression are examples of such conditions. The section on Lamitor DT 50 Tablet contraindications lists all such conditions.
Besides this, Lamitor DT 50 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Lamitor DT 50 Tablet is not safe while driving, and is not addiction.
Lamitor DT 50 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Lamitor DT 50 Tablet safe for pregnant women?
Lamitor may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Lamitor again without your doctor's advice.
Is the use of Lamitor DT 50 Tablet safe during breastfeeding?
Lamitor can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Lamitor DT 50 Tablet on the Kidneys?
Lamitor rarely affects the kidneys.
What is the effect of Lamitor DT 50 Tablet on the Liver?
Lamitor may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Lamitor DT 50 Tablet on the Heart?
Using Lamitor does not have any harmful effects on the heart.
Lamitor DT 50 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lamitor DT 50 Tablet unless your doctor advises you to do so -
Is this Lamitor DT 50 Tablet habit forming or addictive?
No, there is no any evidence that Lamitor DT 50 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Lamitor DT 50 Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Lamitor DT 50 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Lamitor DT 50 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Lamitor DT 50 Tablet
It is safe to take Lamitor DT 50 Tablet with food.
Interaction between Alcohol and Lamitor DT 50 Tablet
Taking Lamitor DT 50 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 742- 744
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lamictal (lamotrigine)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lamitan (lamotrigine)
